Januzzi, J. L., Butler, J., Felker, G. M., Fombu, E., Maisel, A., McCague, K., … Solomon, S. (2017). RATIONALE AND METHODS OF THE PROSPECTIVE STUDY OF BIOMARKERS, SYMPTOM IMPROVEMENT AND VENTRICULAR REMODELING DURING ENTRESTO THERAPY FOR HEART FAILURE (PROVE-HF) STUDY. In Journal of the American College of Cardiology (Vol. 69, pp. 711–711). Elsevier BV. https://doi.org/10.1016/s0735-1097(17)34100-1

Januzzi, James L., Javed Butler, G Michael Felker, Emmanuel Fombu, Alan Maisel, Kevin McCague, Ileana Pina, Margaret Prescott, Jerome Riebman, and Scott Solomon. “RATIONALE AND METHODS OF THE PROSPECTIVE STUDY OF BIOMARKERS, SYMPTOM IMPROVEMENT AND VENTRICULAR REMODELING DURING ENTRESTO THERAPY FOR HEART FAILURE (PROVE-HF) STUDY.” In Journal of the American College of Cardiology, 69:711–711. Elsevier BV, 2017. https://doi.org/10.1016/s0735-1097(17)34100-1.

Januzzi JL, Butler J, Felker GM, Fombu E, Maisel A, McCague K, et al. RATIONALE AND METHODS OF THE PROSPECTIVE STUDY OF BIOMARKERS, SYMPTOM IMPROVEMENT AND VENTRICULAR REMODELING DURING ENTRESTO THERAPY FOR HEART FAILURE (PROVE-HF) STUDY. In: Journal of the American College of Cardiology. Elsevier BV; 2017. p. 711–711.

Januzzi, James L., et al. “RATIONALE AND METHODS OF THE PROSPECTIVE STUDY OF BIOMARKERS, SYMPTOM IMPROVEMENT AND VENTRICULAR REMODELING DURING ENTRESTO THERAPY FOR HEART FAILURE (PROVE-HF) STUDY.” Journal of the American College of Cardiology, vol. 69, no. 11, Elsevier BV, 2017, pp. 711–711. Crossref, doi:10.1016/s0735-1097(17)34100-1.

Januzzi JL, Butler J, Felker GM, Fombu E, Maisel A, McCague K, Pina I, Prescott M, Riebman J, Solomon S. RATIONALE AND METHODS OF THE PROSPECTIVE STUDY OF BIOMARKERS, SYMPTOM IMPROVEMENT AND VENTRICULAR REMODELING DURING ENTRESTO THERAPY FOR HEART FAILURE (PROVE-HF) STUDY. Journal of the American College of Cardiology. Elsevier BV; 2017. p. 711–711.